Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients

Archives of Internal Medicine

Volumn 160, Issue 10, 2000, Pages 1485-1488

  Keyser, Linda A ^a   Karl, Margaret ^b   Nafziger, Anne N ^b,c   Bertino Jr , Joseph S ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b BASSETT HEALTHCARE   (United States)

^c BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; RIMANTADINE;

AGED; ARTICLE; CONFUSION; FEMALE; HUMAN; INFECTION PREVENTION; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; NURSING HOME; PRIORITY JOURNAL;

EID: 0034701832     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.10.1485     Document Type: Article

References (8)

1. Advisory Committee on Immunization Practices. Prevention and control of influenza. MMWR Morb Mortal Wkly Rep. 1998;47(RR-6):1-26.
2. Guay DRP. Amantadine and rimantadine prophylaxis of influenza A in nursing homes. Drugs Aging. 1994;5:8-19.
3. Tominack RL, Hayden FG. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infect Dis Clin North Am. 1987;1: 459-479.
4. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
5. SAS User's Guide. Cary, NC: SAS Institute; 1985.
6. Dolin R, Reichman RD, Madore HP, Maynard R, Linton PN, Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982;307:580-584.
7. Millett VM, Dreisbach M, Bryson YJ. Double-blind controlled study of central nervous system side effects of amantadine, rimantadine and chlorpheniramine. Antimicrob Agents Chemother. 1982;21:1-4.
8. Hayden FG, Hoffman HE, Spyker DA. Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics. Antimicrob Agents Chemother. 1983;23:458-464.